NVCR - NovoCure Limited

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
No. of Analysts8888
Avg. Estimate00.020.130.44
Low Estimate-0.03-0.01-0.010.06
High Estimate0.040.060.321.35
Year Ago EPS-0.010.02-0.070.13
Revenue EstimateCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
No. of Analysts8888
Avg. Estimate105.9M110.32M432.29M530.36M
Low Estimate101.86M107.3M414M480.1M
High Estimate110M115M443.5M616.4M
Year Ago Sales80.24M92.06M351.32M432.29M
Sales Growth (year/est)32.00%19.80%23.00%22.70%
Earnings History6/29/20199/29/201912/30/20193/30/2020
EPS Est.-0.07-0.050.020.02
EPS Actual-0.010.020.040.04
Difference0.060.070.020.02
Surprise %85.70%140.00%100.00%100.00%
EPS TrendCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
Current Estimate00.020.130.44
7 Days Ago0.030.040.180.64
30 Days Ago0.060.070.260.66
60 Days Ago0.090.10.420.84
90 Days Ago0.090.110.390.77
EPS RevisionsCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
Up Last 7 Days222N/A
Up Last 30 Days232N/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days3333
Growth EstimatesNVCRIndustrySectorS&P 500
Current Qtr.100.00%N/AN/A-0.34
Next Qtr.N/AN/AN/A-0.12
Current Year285.70%N/AN/A-0.18
Next Year238.50%N/AN/A0.26
Next 5 Years (per annum)60.00%N/AN/A0.04
Past 5 Years (per annum)N/AN/AN/AN/A